Company
PROCEPT BioRobotics
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
9
510(k), De Novo and PMA
Device trials
11
As lead sponsor, any status
Adverse event reports
244
Received Nov 1, 2025 to Nov 20, 2026
Recall records
2
One per recalled product
PROCEPT BioRobotics is on our public-company list (ticker PRCT). Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
PRCT
Nasdaq · PROCEPT BioRobotics Corp
Public float
$3.20B
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$308M
Fiscal year ending Dec 31, 2025
Net income
-$95.6M
Fiscal year ending Dec 31, 2025
R&D spending
$71.3M
Fiscal year ending Dec 31, 2025
Cash
$218M
As of Sep 30, 2026
Long-term debt
$51.8M
As of Sep 30, 2026
Shares outstanding
57.5M
As of Oct 29, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2024 | – | $165M | – | – |
| 2023 | – | $162M | – | – |
| 2021 | $172M | – | – | – |
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
Company details
From the company's latest Form D.
- Legal name
- PROCEPT BioRobotics Corp
- Headquarters
- Redwood City, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1588978 ↗
Executives, directors and promoters
As listed on the latest Form D.
11 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
The 8 newest of 9 since 2015.
K260723 · Decided Jul 9, 2026 · 126 days after receipt
Device type: Fluid Jet Removal System (PZP) · General & Plastic Surgery
- AQUABEAM Robotic System510(k)
K253211 · Decided Jun 23, 2026 · 267 days after receipt
Device type: Fluid Jet Removal System (PZP) · General & Plastic Surgery
K251082 · Decided Oct 10, 2025 · 184 days after receipt
Device type: Fluid Jet Removal System (PZP) · General & Plastic Surgery
6 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- WATER IV PCa (AS Sub-study)Pivotal-lookingRecruiting
NCT07650448 · 333 participants (planned) · Start Sep 11, 2026 · Primary completion Dec 2028
Device: Aquablation Therapy · For: Localized Prostate Cancer
Sites: Chandler, Arizona; Los Angeles, California; Murrieta, California · 28 sites in all
- WATER IV Prostate CancerPivotal-lookingActive, not recruiting
NCT06651632 · 280 participants (planned) · Start Feb 3, 2025 · Primary completion Jul 2027
Device: Aquablation Therapy · For: Localized Prostate Cancer
Sites: Chandler, Arizona; Mesa, Arizona; Los Angeles, California · 37 sites in all
- PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTsActive, not recruiting
NCT06051942 · 125 participants · Start Nov 22, 2022 · Primary completion Jul 2026
Device: Robotic Waterjet Treatment · For: Benign Prostatic Hyperplasia; Localized Prostate Cancer
Sites: La Mesa, California; Glenview, Illinois; Alexandria, Virginia · 6 sites in all
8 more trials with a free account
Reports received
244
Received Nov 1, 2025 to Nov 20, 2026. Includes 3 of another or unstated type.
Malfunction reports
81
33% of reports
Injury reports
149
61% of reports
Death reports
11
4.5% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 20 | 15 | 0 | 0 |
| Jan 24 | 10 | 8 | 0 | 0 |
| Feb 24 | 11 | 15 | 0 | 0 |
| Mar 24 | 26 | 24 | 1 | 0 |
| Apr 24 | 7 | 10 | 0 | 0 |
| May 24 | 14 | 12 | 0 | 0 |
| Jun 24 | 14 | 8 | 1 | 0 |
| Jul 24 | 12 | 22 | 1 | 0 |
| Aug 24 | 17 | 8 | 3 | 0 |
| Sep 24 | 7 | 7 | 0 | 0 |
| Oct 24 | 8 | 10 | 1 | 0 |
| Nov 24 | 12 | 11 | 4 | 0 |
| Dec 24 | 13 | 12 | 0 | 0 |
| Jan 25 | 5 | 22 | 0 | 0 |
| Feb 25 | 20 | 14 | 0 | 0 |
| Mar 25 | 30 | 21 | 1 | 0 |
| Apr 25 | 8 | 14 | 0 | 0 |
| May 25 | 7 | 13 | 0 | 0 |
| Jun 25 | 16 | 11 | 0 | 0 |
| Jul 25 | 12 | 14 | 0 | 0 |
| Aug 25 | 3 | 10 | 0 | 0 |
| Sep 25 | 11 | 9 | 0 | 0 |
| Oct 25 | 9 | 10 | 1 | 0 |
| Nov 25 | 4 | 5 | 1 | 0 |
| Dec 25 | 5 | 15 | 1 | 0 |
| Jan 26 | 11 | 7 | 1 | 0 |
| Feb 26 | 5 | 11 | 1 | 0 |
| Mar 26 | 10 | 20 | 0 | 0 |
| Apr 26 | 6 | 23 | 3 | 0 |
| May 26 | 3 | 7 | 2 | 0 |
| Jun 26 | 7 | 17 | 0 | 0 |
| Jul 26 | 6 | 14 | 0 | 1 |
| Aug 26 | 11 | 14 | 0 | 1 |
| Sep 26 | 7 | 8 | 1 | 0 |
| Oct 26 | 6 | 8 | 1 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
3 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- AQUABEAM Handpiece, REF: HP2000, a sterile single-use component of the AQUABEAM Robotic System.Open, Classified
Z-2330-2021 · Started Jul 9, 2021
Reason given: Scope tube tip may detach from the telescoping tube, which is attached to a single-use handpiece, a component of an aquablation robotic system. Both tip detachment and entire tip separation form the handpiece may lead to procedural delay for handpiece exchange. Tip detachment can be seen cystoscopically and tip...
Cause as FDA categorized it: Component change control · Device type: Fluid Jet Removal System (PZP)
Z-1110-2019 · Started Mar 6, 2019
Reason given: Certain lots may develop an internal leak due to a micro-crack in a specific weld joint within the device. When the Robot detects this failure, it immediately renders the device inoperable and notifies the user via an error message, which may cause delay and/or inability to complete the procedure.
Cause as FDA categorized it: Process control · Device type: Fluid Jet Removal System (PZP)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.